|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net Income (loss) | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities: | |||||
| Depreciation of property and equipment | |||||
| Depreciation expense | |||||
| Amortization of intangible assets | |||||
| Amortization of finance lease right-of-use assets | |||||
| Loss on disposal of assets | |||||
| Loss (gain) on disposal of assets | |||||
| Deferred income tax | |||||
| Gain from PPP loan forgiveness | |||||
| Due to seller non-cash | |||||
| Accretion of discount related to restricted investments | |||||
| Loss on equity method investments | |||||
| Bad debt expense | |||||
| Stock-based compensation | |||||
| Loss on remeasurement of operating and finance leases | |||||
| Loss on liquidation of business | |||||
| Gain on remeasurement of warrant liabilities | |||||
| Gain on bargain purchase | |||||
| Finite-lived intangible asset impairment | |||||
| Intangible asset impairment | |||||
| Goodwill impairment | |||||
| Equity investment impairment | |||||
| Loss (gain) on change in fair value of contingent consideration | |||||
| CRMS | |||||
| Total loss (gain) on change in fair value of contingent consideration | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Asset held for sale | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Operating lease liabilities and right-of-use assets | |||||
| Net cash provided by (used in) operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Purchase of property and equipment | |||||
| Purchase of intangibles | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Purchase of restricted investments | |||||
| Purchase of equity method investments | |||||
| Purchase of equity securities | |||||
| Proceeds from sale and maturity of restricted investments | |||||
| Proceeds from disposal of property and equipment | |||||
| Acquisition of leased assets | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from revolving credit line | |||||
| Repayments of revolving credit line | |||||
| Proceeds from notes payable | |||||
| Repayments of notes payable | |||||
| Due to seller | |||||
| Acquisition of noncontrolling interest | |||||
| Distributions paid to noncontrolling interest | |||||
| Noncontrolling Interest, Increase from Sale of Parent Equity Interest | |||||
| Proceeds from exercise of stock options | |||||
| Acquisition of UK Ltd remaining 20% shares | |||||
| Payments for taxes related to shares withheld for employee taxes | |||||
| Common stock repurchased | |||||
| Equity costs | |||||
| Payments on obligations under finance lease | |||||
| Issuance costs related to merger recapitalization | |||||
| Proceeds from issuance of Class A common stock, net of transaction cost | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net (decrease) increase in cash, cash equivalents, restricted cash and restricted cash equivalents | |||||
| Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period | |||||
| Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period | |||||
| Supplemental disclosure of cash and non-cash transactions: | |||||
| Cash paid for interest | |||||
| Cash paid for interest on finance lease liabilities | |||||
| Cash paid for income taxes, net of refunds | |||||
| Right-of-use assets obtained in exchange for lease liabilities | |||||
| Remeasurement of finance lease right-of-use asset due to lease modification | |||||
| Fixed assets acquired in exchange for notes payable | |||||
| Supplemental non-cash investing and financing activities: | |||||
| Property and equipment in accounts payable | |||||
| Acquisition of remaining FMC NA through due to seller and issuance of stock | |||||
| FMC NA | |||||
| CRMS | |||||
| CRMS True-up Payment through issuance of stock | |||||
| Receivables exchanged for trade credits | |||||
| Pre-acquisition receivables written off through due to seller | |||||
| Reconciliation of cash and restricted cash | |||||
| Cash | |||||
| Restricted cash | |||||
Loading...